Selected research
Market Outlook & Growth Opportunities
Global Gut Microbiome Testing Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Gut Microbiome Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Gut Microbiome Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Gut Microbiome Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gut Microbiome Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Gut Microbiome Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Gut Microbiome Testing Service market include Biomesight, Carbiotix, EasyDNA, Floré Microbiome Gut Test, Genetic Analysis, GUTolution, Invivo Healthcare, Jona and Kean Health, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Gut Microbiome Testing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Gut Microbiome Testing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Gut Microbiome Testing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Gut Microbiome Testing Service market.
Gut Microbiome Testing Service Segment by Company
Biomesight
Carbiotix
EasyDNA
Floré Microbiome Gut Test
Genetic Analysis
GUTolution
Invivo Healthcare
Jona
Kean Health
Microba
Ombre
Randox Health
Sun Genomics
Tiny Health
Viome
Gut Microbiome Testing Service Segment by Type
Gene Sequencing-Based Testing Services
Culture-Based Testing Services
Metabolite-Based Testing Services
Gut Microbiome Testing Service Segment by Application
Health Assessment
Disease Diagnosis and Treatment
Nutrition and Health Guidance
Gut Microbiome Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Gut Microbiome Testing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Gut Microbiome Testing Service key companies, revenue, market share, and recent developments.
3. To split the Gut Microbiome Testing Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Gut Microbiome Testing Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Gut Microbiome Testing Service significant trends, drivers, influence factors in global and regions.
6. To analyze Gut Microbiome Testing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gut Microbiome Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gut Microbiome Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gut Microbiome Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gut Microbiome Testing Service industry.
Chapter 3: Detailed analysis of Gut Microbiome Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Gut Microbiome Testing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Gut Microbiome Testing Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Gene Sequencing-Based Testing Services
- Culture-Based Testing Services
- Metabolite-Based Testing Services
Applications
- Health Assessment
- Disease Diagnosis and Treatment
- Nutrition and Health Guidance
Companies covered
- Biomesight
- Carbiotix
- EasyDNA
- Floré Microbiome Gut Test
- Genetic Analysis
- GUTolution
- Invivo Healthcare
- Jona
- Kean Health
- Microba
- Ombre
- Randox Health
- Sun Genomics
- Tiny Health
- Viome
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Gut Microbiome Testing Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Gut Microbiome Testing Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Gut Microbiome Testing Service Market Dynamics
- 2.1 Gut Microbiome Testing Service Industry Trends
- 2.2 Gut Microbiome Testing Service Industry Drivers
- 2.3 Gut Microbiome Testing Service Industry Opportunities and Challenges
- 2.4 Gut Microbiome Testing Service Industry Restraints
3 Gut Microbiome Testing Service Market by Company
- 3.1 Global Gut Microbiome Testing Service Company Revenue Ranking in 2025
- 3.2 Global Gut Microbiome Testing Service Revenue by Company (2021-2026)
- 3.3 Global Gut Microbiome Testing Service Company Ranking (2024-2026)
- 3.4 Global Gut Microbiome Testing Service Company Manufacturing Base and Headquarters
- 3.5 Global Gut Microbiome Testing Service Company Product Type and Application
- 3.6 Global Gut Microbiome Testing Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Gut Microbiome Testing Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Gut Microbiome Testing Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Gut Microbiome Testing Service Market by Type
- 4.1 Gut Microbiome Testing Service Type Introduction
- 4.1.1 Gene Sequencing-Based Testing Services
- 4.1.2 Culture-Based Testing Services
- 4.1.3 Metabolite-Based Testing Services
- 4.2 Global Gut Microbiome Testing Service Sales Value by Type
- 4.2.1 Global Gut Microbiome Testing Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Gut Microbiome Testing Service Sales Value by Type (2021-2032)
- 4.2.3 Global Gut Microbiome Testing Service Sales Value Share by Type (2021-2032)
5 Gut Microbiome Testing Service Market by Application
- 5.1 Gut Microbiome Testing Service Application Introduction
- 5.1.1 Health Assessment
- 5.1.2 Disease Diagnosis and Treatment
- 5.1.3 Nutrition and Health Guidance
- 5.2 Global Gut Microbiome Testing Service Sales Value by Application
- 5.2.1 Global Gut Microbiome Testing Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Gut Microbiome Testing Service Sales Value by Application (2021-2032)
- 5.2.3 Global Gut Microbiome Testing Service Sales Value Share by Application (2021-2032)
6 Gut Microbiome Testing Service Regional Value Analysis
- 6.1 Global Gut Microbiome Testing Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Gut Microbiome Testing Service Sales Value by Region (2021-2032)
- 6.2.1 Global Gut Microbiome Testing Service Sales Value by Region: 2021-2026
- 6.2.2 Global Gut Microbiome Testing Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Gut Microbiome Testing Service Sales Value (2021-2032)
- 6.3.2 North America Gut Microbiome Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Gut Microbiome Testing Service Sales Value (2021-2032)
- 6.4.2 Europe Gut Microbiome Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Gut Microbiome Testing Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Gut Microbiome Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Gut Microbiome Testing Service Sales Value (2021-2032)
- 6.6.2 South America Gut Microbiome Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Gut Microbiome Testing Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Gut Microbiome Testing Service Sales Value Share by Country, 2025 VS 2032
7 Gut Microbiome Testing Service Country-level Value Analysis
- 7.1 Global Gut Microbiome Testing Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Gut Microbiome Testing Service Sales Value by Country (2021-2032)
- 7.2.1 Global Gut Microbiome Testing Service Sales Value by Country (2021-2026)
- 7.2.2 Global Gut Microbiome Testing Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Gut Microbiome Testing Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Gut Microbiome Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Gut Microbiome Testing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Biomesight
- 8.1.1 Biomesight Company Information
- 8.1.2 Biomesight Business Overview
- 8.1.3 Biomesight Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 8.1.4 Biomesight Gut Microbiome Testing Service Product Portfolio
- 8.1.5 Biomesight Recent Developments
- 8.2 Carbiotix
- 8.2.1 Carbiotix Company Information
- 8.2.2 Carbiotix Business Overview
- 8.2.3 Carbiotix Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 8.2.4 Carbiotix Gut Microbiome Testing Service Product Portfolio
- 8.2.5 Carbiotix Recent Developments
- 8.3 EasyDNA
- 8.3.1 EasyDNA Company Information
- 8.3.2 EasyDNA Business Overview
- 8.3.3 EasyDNA Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 8.3.4 EasyDNA Gut Microbiome Testing Service Product Portfolio
- 8.3.5 EasyDNA Recent Developments
- 8.4 Floré Microbiome Gut Test
- 8.4.1 Floré Microbiome Gut Test Company Information
- 8.4.2 Floré Microbiome Gut Test Business Overview
- 8.4.3 Floré Microbiome Gut Test Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Floré Microbiome Gut Test Gut Microbiome Testing Service Product Portfolio
- 8.4.5 Floré Microbiome Gut Test Recent Developments
- 8.5 Genetic Analysis
- 8.5.1 Genetic Analysis Company Information
- 8.5.2 Genetic Analysis Business Overview
- 8.5.3 Genetic Analysis Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Genetic Analysis Gut Microbiome Testing Service Product Portfolio
- 8.5.5 Genetic Analysis Recent Developments
- 8.6 GUTolution
- 8.6.1 GUTolution Company Information
- 8.6.2 GUTolution Business Overview
- 8.6.3 GUTolution Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 8.6.4 GUTolution Gut Microbiome Testing Service Product Portfolio
- 8.6.5 GUTolution Recent Developments
- 8.7 Invivo Healthcare
- 8.7.1 Invivo Healthcare Company Information
- 8.7.2 Invivo Healthcare Business Overview
- 8.7.3 Invivo Healthcare Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 8.7.4 Invivo Healthcare Gut Microbiome Testing Service Product Portfolio
- 8.7.5 Invivo Healthcare Recent Developments
- 8.8 Jona
- 8.8.1 Jona Company Information
- 8.8.2 Jona Business Overview
- 8.8.3 Jona Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 8.8.4 Jona Gut Microbiome Testing Service Product Portfolio
- 8.8.5 Jona Recent Developments
- 8.9 Kean Health
- 8.9.1 Kean Health Company Information
- 8.9.2 Kean Health Business Overview
- 8.9.3 Kean Health Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Kean Health Gut Microbiome Testing Service Product Portfolio
- 8.9.5 Kean Health Recent Developments
- 8.10 Microba
- 8.10.1 Microba Company Information
- 8.10.2 Microba Business Overview
- 8.10.3 Microba Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 8.10.4 Microba Gut Microbiome Testing Service Product Portfolio
- 8.10.5 Microba Recent Developments
- 8.11 Ombre
- 8.11.1 Ombre Company Information
- 8.11.2 Ombre Business Overview
- 8.11.3 Ombre Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 8.11.4 Ombre Gut Microbiome Testing Service Product Portfolio
- 8.11.5 Ombre Recent Developments
- 8.12 Randox Health
- 8.12.1 Randox Health Company Information
- 8.12.2 Randox Health Business Overview
- 8.12.3 Randox Health Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 8.12.4 Randox Health Gut Microbiome Testing Service Product Portfolio
- 8.12.5 Randox Health Recent Developments
- 8.13 Sun Genomics
- 8.13.1 Sun Genomics Company Information
- 8.13.2 Sun Genomics Business Overview
- 8.13.3 Sun Genomics Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 8.13.4 Sun Genomics Gut Microbiome Testing Service Product Portfolio
- 8.13.5 Sun Genomics Recent Developments
- 8.14 Tiny Health
- 8.14.1 Tiny Health Company Information
- 8.14.2 Tiny Health Business Overview
- 8.14.3 Tiny Health Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 8.14.4 Tiny Health Gut Microbiome Testing Service Product Portfolio
- 8.14.5 Tiny Health Recent Developments
- 8.15 Viome
- 8.15.1 Viome Company Information
- 8.15.2 Viome Business Overview
- 8.15.3 Viome Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 8.15.4 Viome Gut Microbiome Testing Service Product Portfolio
- 8.15.5 Viome Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst